Effects of low-dose milnacipran on event-related potentials and neuropsychological tests in persons with traumatic brain injury: A preliminary study

References

• Zang L, Plotkin RC, Wang G, Sandel ME, Lee S. Cholinergic augmentation with donepezil enhances recovery in short-term memory and sustained attention after traumatic brain injury. Archives of Physical Medicine and Rehabilitation 2004;85:1050–1055
   PubMed Web of Science ®Google Scholar
• Pae CU, Marks DM, Shah M, Han C, Patkar AA, Masand PS. Milnacipran: Beyond a role of antidepressant. Clinical Neuropharmacology 2009;32:355–363
   PubMed Web of Science ®Google Scholar
• Tignol J, Pujol-Domenech J, Chartres JP, Léger JM, Plétan Y, Tonelli I, Tournoux A, Pezous N. Double-blind study of the efficacy and safety of milnacipran and imipramine in elderly patients with major depressive episode. Acta Psychiatrica Scandinavica 1998;97:157–164
   PubMed Web of Science ®Google Scholar
• Kanetani K, Kimura M, Endo S. Therapeutic effects of milnacipran (serotonin noradrenalin reuptake inhibitor) on depression following mild and moderate traumatic brain injury. Journal of Nippon Medical School 2003;70:313–320
   PubMedGoogle Scholar
• Kok A. Event-related-potential (ERP) reflections of mental resources: A review and synthesis. Biological Psychology 1997;45:19–56
   PubMed Web of Science ®Google Scholar
• Kok A. Age-related changes in involuntary and voluntary attention as reflected in components of the event-related potential (ERP). Biological Psychology 2000;54:107–143
   PubMed Web of Science ®Google Scholar
• Wilson JTL, Pettigrew LEL, Teasdale GM. Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: Guidelines for their use. Journal of Neurotrauma 1998;15:573–585
   PubMed Web of Science ®Google Scholar
• Zung WW. A Self-Rating Depression Scale. Archives of General Psychiatry 1965;12:63–70
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 1983;67:361–370
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edn. Washington, DC: American Psychiatric Press Inc.; 1994
   Google Scholar
• Sato S, Yamakawa Y, Terashima Y, Ohta H, Asada T. Efficacy of milnacipran on cognitive dysfunction with post-stroke depression: Preliminary open-label study. Psychiatry and Clinical Neurosciences 2006;60:584–589
   PubMed Web of Science ®Google Scholar
• Goodin D, Desmedt J, Maurer K, Nuwer MR. IFCN recommended standards for long-latency auditory event-related potentials. Report of an IFCN committee. International Federation of Clinical Neurophysiology. Electroencephalography and Clinical Neurophysiology 1994;91:18–20
   PubMedGoogle Scholar
• Lewis GW. Temporal stability of multichannel, multimodal ERP recordings. International Journal of Neuroscience 1984;25:131–144
   PubMed Web of Science ®Google Scholar
• Shinha R, Bernardy N, Parsons OA. Long-term test-retest reliability of event-related potentials in normal and alcoholics. Biological Psychiatry 1992;32:992–1003
   PubMed Web of Science ®Google Scholar
• Spikman JM, Van der Naalt J, Van Weerden TW, Van Zomeren AH. Indices of slowness of information processing in head injury patients: Tests for selective attention related to ERP latencies. Journal of the International Neuropsychological Society 2004;10:851–861
   PubMed Web of Science ®Google Scholar
• Donchin E, Coles MGH. Is the P300 component a manifestation of context updating? Behavioral and Brain Sciences 1988;11:355–372
   Web of Science ®Google Scholar
• Neshige R, Barrett G, Shibasaki H. Auditory long latency event-related potentials in Alzheimer’s disease and multi-infarct dementia. Journal of Neurology, Neurosurgery, and Psychiatry 1988;51:1120–1125
   PubMed Web of Science ®Google Scholar
• Pehrson AL, Leiser SC, Gulinello M, Dale E, Li Y, Waller JA, Sanchez C. Treatment of cognitive dysfunction in major depressive disorder-a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine. European Journal of Pharmacology 2015;753:19–31
   PubMed Web of Science ®Google Scholar
• Horsfield SA, Rosse RB, Tomasino V, Schwartz BL, Mastropaolo J, Deutsch SI. Fluoxetine’s effects on cognitive performance in patients with traumatic brain injury. International Journal of Psychiatry in Medicine 2002;32:337–344
   PubMed Web of Science ®Google Scholar
• Jackson RD, Corrigan JD, Arnett JA. Amitriptyline for agitation in head injury. Archives of Physical Medicine and Rehabilitation 1985;66:180–181
   PubMed Web of Science ®Google Scholar
• Fann JR, Uomoto JM, Katon WJ. Cognitive improvement with treatment of depression following mild traumatic brain injury. Psychosomatics 2001;42:48–54
   PubMed Web of Science ®Google Scholar
• Lee H, Kim SW, Kim JM, Shin IS, Yang SJ, Yoon JS. Comparing effects of methylphenidate, sertraline, and placebo on neuropsychiatric sequelae in patients with traumatic brain injury. Human Psychopharmacology 2005;20:97–104
   PubMed Web of Science ®Google Scholar
• Saniova B, Drobny M, Kneslova L, Minarik M. The outcome of patients with severe head injuries treated with amantadine sulphate. Journal of Neural Transmission 2004;111:511–514
   PubMed Web of Science ®Google Scholar
• Kaye NS, Townsend JB III, Ivins R. An open-label trial of donepezil (aricept) in the treatment of persons with mild traumatic brain injury. Journal of Neuropsychiatry and Clinical Neurosciences 2003;15:383–384
   PubMed Web of Science ®Google Scholar
• Levin HS, Peters BH, Kalisky Z, High WM Jr, von Laufen A, Eisenberg HM, Morrison DP, Gary HE Jr. Effects of oral physostigmine and lecithin on memory and attention in closed head-injured patients. Central Nervous System Trauma 1986;3:333–342
   PubMedGoogle Scholar
• Zhang L, Plotkin RC, Wang G, Sandel ME, Lee S. Cholinergic augmentation with donepezil enhances recovery in short-term memory and sustained attention after traumatic brain injury. Archives of Physical Medicine and Rehabilitation 2004;85:1050–1055
   PubMed Web of Science ®Google Scholar
• Khateb A, Ammann J, Annoni JM, Diserens K. Cognition-enhancing effects of donepezil in traumatic brain injury. European Neurology 2005;54:39–45
   PubMed Web of Science ®Google Scholar